The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
Open accessAbstract
Moloney Murine Leukemia Virus (MoMuLV) causes T cell neoplasms in rodents but is not known to be a pathogen in primates. The core protein and enzyme genes of the MoMuLV genome together with an amphotropic envelope gene are utilized to engineer the cell lines that generate retroviral vectors for use in current human gene therapy applications. We developed a producer clone that generates a very high concentration of retroviral vector particles to optimize conditions for gene insertion into pluripotent hematopoietic stem cells. This producer cell line also generates a much lower concentration of replication-competent virus that arose through recombination. Stem cells from rhesus monkeys were purified by immunoselection with an anti-CD34 antibody, incubated in vitro for 80-86 h in the presence of retroviral vector particles with accompanying replication-competent virus and used to reconstitute recipients whose bone marrow had been ablated by total body irradiation. The retroviral vector genome was detected in circulating cells of five of eight transplant recipients of CD34+ cells and in the circulating cells of two recipients of infected, unfractionated bone marrow mononuclear cells. Three recipients of CD34+ cells had a productive infection with replication-competent virus. Six or seven mo after transplantation, each of these animals developed a rapidly progressive T cell neoplasm involving the thymus, lymph nodes, liver, spleen, and bone marrow. Lymphoma cells contained 10-50 copies of the replication-competent virus, but lacked the retroviral vector genome. We conclude that replication-competent viruses arising from producer cells making retroviral vectors can be pathogenic in primates, which underscores the importance of carefully screening retroviral producer clones used in human trials to exclude contamination with replication-competent virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although viral vectors have been widely used in the delivery of the CRISPR/Cas9 system in vitro and in vivo, their fundamental shortcomings, such as the risk of carcinogenesis, limited insertion size, immune responses and difficulty in large-scale production, severely limit their further applications.”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,990
Mann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,776
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895-2902.1986 · Cited by 1,371
Granulocyte colony-stimulating factor and its receptor
Demetri, G. D., & Griffin, J. D. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,066
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S. P., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,062
Danos, O., & Mulligan, R. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6460 · Cited by 898
Yang, Y., Ciarletta, A. B., Temple, P. A., Chung, M. P., Kovacic, S., Witek-Giannotti, J. S., Leary, A. C., Kriz, R., Donahue, R. E., Wong, G. G., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90360-0 · Cited by 766
Self-citationPrimary structure and functional expression of rat and human stem cell factor DNAs
Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I., Jacobsen, F. W., Mendlaz, E. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90301-t · Cited by 719
Cited by
Sorted by citations
Items 201–300 of 525
Gene Transfer into Nonhuman Primate Hematopoietic Stem Cells: Implications for Gene Therapy
Hanazono, Y., Terao, K., & Ozawa, K. (2001) · Stem Cells · doi:10.1634/stemcells.19-1-12 · Cited by 29
Retrovirus-mediated gene transfer in cancer therapy
Uckert, W., & Walther, W. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90029-9 · Cited by 29
Yu, S. S., Han, E., Hong, Y., Lee, J.-T., Kim, S., & Kim, S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301892 · Cited by 28
Adeno-associated virus-mediated gene delivery
Snyder, R. O. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3 · Cited by 106
Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy
Kohn, D. B. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.006 · Cited by 28
Logg, C. R., Baranick, B. T., Lemp, N. A., & Kasahara, N. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.026 · Cited by 27
Hematopoietic stem cell gene therapy: dead or alive?
Ferguson, C., Larochelle, A., & Dunbar, C. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.09.005 · Cited by 30
Self-citationThe design of retroviral vectors used in the CAR‐T products, risk management, and future perspective
Yin, H., & Wei, X. (2025) · MedComm · doi:10.1002/mco2.70067 · Cited by 27
N4,N9-Dioleoyl Spermine Is a Novel Nonviral Lipopolyamine Vector for Plasmid DNA Formulation
Ahmed, O. A. A., Adjimatera, N., Pourzand, C., & Blagbrough, I. S. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4592-1 · Cited by 26
Genetic manipulation of hematopoietic stem cells.
Larochelle, A., & Dunbar, C. (2004) · Seminars in hematology (Print) · doi:10.1053/j.seminhematol.2004.07.002 · Cited by 22
Self-citationSmiley, W. R., Laubert, B., HOWARD, B. D., Ibañez, C. E., Fong, T. C., Summers, W. S., & Burrows, F. J. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.8-965 · Cited by 26
Transfer of the cytidine deaminase cDNA into hematopoietic cells
Flaßhove, M., Frings, W., Schröder, J., Moritz, T., Schütte, J., & Seeber, S. (1999) · Leukemia Research · doi:10.1016/s0145-2126(99)00128-9 · Cited by 25
Introduction to cancer gene therapy
Cusack, J. C., & Tanabe, K. K. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00029-7 · Cited by 25
Gene Transfer into Hematopoietic Cells: Implications for Cancer Therapy
Dunbar, C. E., Bodine, D. M., Sorrentino, B. P., Donahue, R. E., McDonagh, K. T., Cottler‐Fox, M., O'SHAUGHESSY, J., Cowan, K. H., CARTER, C., DOREN, S., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21714.x · Cited by 25
Self-citationDonahue, R., Byrne, E., Thomas, T. E., Kirby, M., Agricola, B., Sellers, S. E., Gaudernack, G., Karisson, S., & Lansdorp, P. (1996) · Blood · doi:10.1182/blood.v88.11.4166.4166 · Cited by 25
Self-citationIn Vitro Gene Delivery with Ultrasound-Triggered Polymer Microbubbles
Cochran, M. C., & Wheatley, M. A. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.01.013 · Cited by 24
Andrews, R. G., Peterson, L. J., Morris, J. C., Potter, J. C., Heyward, S. A., Gough, M., Bryant, E. M., & Kiem, H. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00137-5 · Cited by 24
Chromatin tethering and retroviral integration: Recent discoveries and parallels with DNA viruses
Meehan, A. M., & Poeschla, E. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.10.001 · Cited by 24
Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies
Purow, B. W., & Staveley-O’Carroll, K. F. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.04.022 · Cited by 23
Circumvention of chemotherapy-induced myelosuppression by transfer of themdr1 gene
Boesen, J. J. B., Nooter, K., & Valerio, D. (1993) · Biotherapy · doi:10.1007/bf01878359 · Cited by 23
Gene therapy: progress and challenges.
Meyer, F., & Finer, M. H. (2001) · PubMed · Cited by 23
The contribution of marker gene studies to hemopoietic stem cell therapies
Brenner, M. K. (1995) · Stem Cells · doi:10.1002/stem.5530130502 · Cited by 23
Weißinger, F., Reimer, P., Waessa, T., Buchhofer, S., Schertlin, T., Kunzmann, V., & Wilhelm, M. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2003.14 · Cited by 22
Hematopoietic Stem Cell Gene Therapy: Assessing the Relevance of Preclinical Models
Larochelle, A., & Dunbar, C. E. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.03.025 · Cited by 23
Self-citationGene Therapy Applications for Spine Fusion
Cha, C. W., & Boden, S. D. (2003) · Spine · doi:10.1097/01.brs.0000076902.64395.c3 · Cited by 22
Detection of replication competent retrovirus and lentivirus.
Sastry, L., & Cornetta, K. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-409-4_17 · Cited by 21
Loewen, N. A., & Poeschla, E. M. (2005) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_007 · Cited by 22
Delivering therapeutic genes — matching approach and application
Mitani, K., & Caskey, C. T. (1993) · Trends in biotechnology · doi:10.1016/0167-7799(93)90108-l · Cited by 22
Cohen‐Haguenauer, O. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.6-773 · Cited by 22
Zhang, M., Lute, S. C., Norling, L. A., Hong, C., Safta, A., O'Connor, D., Bernstein, L. J., Wang, H., Blank, G., Brorson, K., et al. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22172 · Cited by 21
Retroviral vector production in the National Gene Vector Laboratory at Indiana University
Cornetta, K., Matheson, L., & Ballas, C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302613 · Cited by 22
Production of High-Titer Retroviral Vectors and Detection of Replication-Competent Retroviruses
Kim, Y. S., Lim, H.-K., & Kim, K.-J. (1998) · Molecules and Cells · doi:10.1016/s1016-8478(23)13389-9 · Cited by 21
Gene transfer to hematopoietic cells — the clinical experience
Richter, J. (1997) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1997.tb00728.x · Cited by 21
Gene Delivery Using Chemical Methods
Lalani, J., & Misra, A. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384964-9.00004-9 · Cited by 20
Miskin, J., Chipchase, D., Rohll, J. B., Beard, G. L., Wardell, T. W., Angell-Manning, D., Roehl, H. H., Jolly, D. J., Kingsman, S. M., & Mitrophanous, K. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302666 · Cited by 20
Maggiorella, M. T., Monardo, F., Koanga-Mogtomo, M. L., Cioé, L., Sernicola, L., Corrias, F., Baroni, C. D., Verani, P., & Titti, F. (1998) · Blood · doi:10.1182/blood.v91.9.3103 · Cited by 20
In Vitro Analysis of Transformation Potential Associated with Retroviral Vector Insertions
Powell, S. K., Kaloss, M., Burimski, I., Weaver, L., Long, Z., Lyons, R. M., McGarrity, G. J., & Otto, E. (1999) · Human Gene Therapy · doi:10.1089/10430349950017112 · Cited by 20
Regulatory review of Cellular and Gene Therapies: An overview of the process
Marti, G. E., Bauer, S. R., Puri, R. K., & Noguchi, P. D. (1994) · Transfusion Science · doi:10.1016/0955-3886(94)90163-5 · Cited by 19
Canuti, M., Williams, C. V., Gadi, S. V., Jebbink, M. F., Munnink, B. B. O., Farsani, S. M. J., Cullen, J. M., & van der Hoek, L. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00655 · Cited by 19
Strauss, D., Lute, S. C., Brorson, K., Blank, G. S., Chen, Q., & Yang, B. (2009) · Biotechnology Progress · doi:10.1002/btpr.249 · Cited by 19
Calcium Phosphate-Mediated DNA Transfection
Chang, P. L. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6822-9_9 · Cited by 19
Powell, S. K., Artlip, M., Kaloss, M., Brazinski, S., Lyons, R. M., McGarrity, G. J., & Otto, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8813-8816.1999 · Cited by 19
Hematti, P., Tuchman, S., Larochelle, A., Metzger, M., Donahue, R., & Tisdale, J. (2004) · Stem Cells · doi:10.1634/stemcells.22-6-1062 · Cited by 21
Self-citationGene Transfer into Human Hematopoietic Progenitor Cells: A Review of Current Clinical Protocols
Brenner, M. K. (1993) · Journal of Hematotherapy · doi:10.1089/scd.1.1993.2.7 · Cited by 19
Hematoprotection by Transfer of Drug-Resistance Genes
Flaßhove, M., Moritz, T., Bardenheuer, W., & Seeber, S. (2003) · Acta Haematologica · doi:10.1159/000072458 · Cited by 18
Toxicities associated with immunotherapies for hematologic malignancies
Leick, M. B., & Maus, M. V. (2018) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2018.03.004 · Cited by 18
Introduction of human adenomatous polyposis coli gene into Min mice via cationic liposomes
Arenas, R. B., Fichera, A., Mok, P., Blanco, M. C., & Michelassi, F. (1996) · Surgery · doi:10.1016/s0039-6060(96)80021-3 · Cited by 18
Kurpad, C., Mukherjee, P., Wang, X.-S., Ponnazhagan, S., Ling-lin, L., Yöder, M. C., & Srivastava, A. (1999) · Stem Cells and Development · doi:10.1089/152581699319740 · Cited by 18
Cusack, J. C., & Tanabe, K. K. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30255-2 · Cited by 18
Heslop, H. E., & Brenner, M. K. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.004 · Cited by 18
Kiem, H., Arumugam, P. I., Burtner, C. R., Fox, C. F., Beard, B. C., Dexheimer, P. J., Adair, J. E., & Malik, P. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.55 · Cited by 19
Keratinocyte Gene Transfer and Gene Therapy
Garlick, J. A., & Fenjves, E. S. (1996) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411960070030101 · Cited by 17
Gene therapy for the hemophilias
Walter, J., & High, K. A. (1997) · Advances in veterinary medicine · doi:10.1016/s0065-3519(97)80006-7 · Cited by 17
Gene therapy for hemophilia: hopes and hurdles
Chuah, M. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00022-5 · Cited by 17
Gene therapy for immune disorders: good news tempered by bad news.
Puck, J., & Malech, H. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.041 · Cited by 15
Pasi, J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03225.x · Cited by 17
Encapsidation and transduction of cellular genes by retroviruses
Rein, A. R. (2003) · Frontiers in bioscience · doi:10.2741/950 · Cited by 17
Protection of MLV Vector Particles from Human Complement
Breun, S. K. J., Salmons, B., Günzburg, W. H., & Baumann, J. G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1474 · Cited by 16
Blömer, U., Ganser, A., & Scherr, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0123-7_16 · Cited by 16
Logg, C. R., & Kasahara, N. (2004) · Humana Press eBooks · doi:10.1385/1-59259-650-9:499 · Cited by 16
Biosafety Issues in Lentivector Production
Delenda, C., Audit, M., & Danos, O. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56114-6_6 · Cited by 16
Mok, P. L., Cheong, S., Leong, C. F., Chua, K. H., & Ainoon, O. (2011) · Cytotechnology · doi:10.1007/s10616-011-9413-2 · Cited by 16
In vitro expression of erythropoietin by transfected human mesenchymal stromal cells
Mok, P. L., Cheong, S., Leong, C. F., & Othman, A. (2008) · Cytotherapy · doi:10.1080/14653240701816996 · Cited by 15
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization
Hu, P., Bi, Y., Ma, H., Suwanmanee, T., Zeithaml, B., Fry, N. J., Kohn, D. B., & Kafri, T. (2018) · Gene Therapy · doi:10.1038/s41434-018-0039-2 · Cited by 15
Pulè, M. A., Rousseau, A., Vera, J. F., Heslop, H., Brenner, M. K., & Vanin, E. F. (2008) · Cytotherapy · doi:10.1080/14653240802192636 · Cited by 15
Wilson, C., & Cichutek, K. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-409-4_32 · Cited by 15
Trajcevski, S., Solly, S. K., Frisén, C., Trenado, A., Cosset, F., & Klatzmann, D. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.663 · Cited by 15
Schmidt‐Wolf, G., & Schmidt‐Wolf, I. G. H. (1994) · Annals of Hematology · doi:10.1007/bf01696555 · Cited by 15
Lentivirus and foamy virus vectors: novel gene therapy tools
Pandya, S., Klimatcheva, E., & Planelles, V. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.1.17 · Cited by 15
Potential Applications of Gene Therapy in the Patient with Cancer
Szlosarek, P. W., & Dalgleish, A. G. (2000) · Drugs & Aging · doi:10.2165/00002512-200017020-00004 · Cited by 14
Genetically Engineered Mesenchymal Stem Cells: The Ongoing Research for Bone Tissue Engineering
Hong, D., Chen, H., Ge, R., & Li, J. (2009) · The Anatomical Record · doi:10.1002/ar.21045 · Cited by 14
Dunbar, C. (2007) · Hematology. American Society of Hematology. Education Program · doi:10.1182/asheducation-2007.1.460 · Cited by 14
Self-citationReducing the Genotoxic Potential of Retroviral Vectors
Ramezani, A., Hawley, T. S., & Hawley, R. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-248-3_12 · Cited by 14
Pathogenesis of early leukemia and lymphoma
Zhao, X. F., Reitz, M. S., Chen, Q. C., & Stass, S. A. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0178 · Cited by 14
Choi, Y., Jeon, Y., Kang, J., Chung, J., Schmidt, M., & Kim, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22567 · Cited by 14
Construction of Recombinant Adeno-Associated Virus Vector Containing the Rat Preproinsulin II Gene
Peng, L., Sidner, R. A., Bochan, M. R., Burton, M. M., Cooper, S. T., & Jindal, R. M. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5079 · Cited by 14
Reeves, L., Duffy, L., Koop, S., Daggy, J., & Cornetta, K. G. (2002) · Human Gene Therapy · doi:10.1089/104303402760293619 · Cited by 14
Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques
Hoatlin, M. E., Kozak, S. L., Spiro, C., & Kabat, D. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00198238 · Cited by 14
Gene Transfer into Fetal Baboon Hematopoietic Progenitor Cells
Winkler, A. R., Kiem, H., Shields, L. E., Sun, Q., & Andrews, R. G. (1999) · Human Gene Therapy · doi:10.1089/10430349950018742 · Cited by 14
Assessing Viral Gene Therapy in Neuroendocrine Models
Geddes, B. J., Harding, T. C., Lightman, S. L., & Uney, J. B. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0184 · Cited by 14
Vectors derived from the human immunodeficiency virus HIV-1
Planelles, V. (2003) · Frontiers in bioscience · doi:10.2741/939 · Cited by 13
Gene marking after bone marrow transplantation
Brenner, M. K., Rill, D. R., Heslop, H., Rooney, C. M., Roberts, W., Li, C., Nilson, T., & Krance, R. A. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90478-2 · Cited by 13
Matory, Y. L., CHEN, M., Dorfman, D. M., Williams, A. L., Goedegebuure, P. S., & Eberlein, T. J. (1995) · Surgery · doi:10.1016/s0039-6060(05)80331-9 · Cited by 13
Sellers, S. E., Tisdale, J. F., Bodine, D. M., Williams, D. A., Karlsson, S., Meztger, M., Donahue, R. E., & Dunbar, C. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018706 · Cited by 13
Self-citationCornetta, K. G., Yao, J., House, K. D., Duffy, L., Adusumilli, P. S., Beyer, R. K., Booth, C., Brenner, M. K., Curran, K. J., Grilley, B., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.12.006 · Cited by 14
Introduction for “Safety Considerations for Retroviral Vectors: A Short Review”
Mosier, D. E. (2004) · Applied Biosafety · doi:10.1177/153567600400900203 · Cited by 12
Andaloussi, A. E., Igboeli, P., Amer, A., & Al-Hendy, A. A. (2018) · Biomedicines · doi:10.3390/biomedicines6030093 · Cited by 12
Duroy, P., Bosshard, S., Schmid‐Siegert, E., Neuenschwander, S., Arib, G., Mercier, P. L., Masternak, J., Roesch, L., Buron, F., Girod, P., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27200 · Cited by 13
Chen, T.-Y., Hsu, C.-T., Chang, K. H., Ting, C., Whang‐Peng, J., Hui, C.-F., & Hwang, J. (2000) · Applied Microbiology and Biotechnology · doi:10.1007/s002530051657 · Cited by 12
Gene-Marking studies of hematopoietic cells
Bollard, C. M., Heslop, H. E., & Brenner, M. K. (2001) · International Journal of Hematology · doi:10.1007/bf02981898 · Cited by 12
Früehauf, S., Wermann, K. M., Buss, E. C., Hundsdoerfer, P., Veldwijk, M. R., Haas, R. R., & Zeller, W. J. (1998) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-46836-0_12 · Cited by 12
Banerjee, P. T., Ierino, F. L., Kaynor, G. C., Giovino, M. A., Hawley, R., Rosa, M. D., LeGuern, C., Sachs, D. H., & Monroy, R. L. (1997) · Xenotransplantation · doi:10.1111/j.1399-3089.1997.tb00181.x · Cited by 12
Biosynthetic retrovectoring systems for gene therapy
Hodgson, C. P., Xu, G., Solaiman, F., & Zink, M. A. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050110 · Cited by 12
How controlled release technology can aid gene delivery
Jo, J., & Tabata, Y. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1048221 · Cited by 11
Gene Therapy: Principles and Clinical Applications in Orthopedics
Parikh, S. N. (2004) · Orthopedics · doi:10.3928/0147-7447-20040301-14 · Cited by 11
Lee, J., & Klein, H. G. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30111-4 · Cited by 11
siRNA Specific Delivery System for Targeting Dendritic Cells
Zheng, X., Vladau, C., Shunner, A., & Min, W. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-588-0_11 · Cited by 11
Gene therapy with physical methods of gene transfer
Matthews, K. E., & Keating, A. (1996) · Transfusion Science · doi:10.1016/0955-3886(95)00055-0 · Cited by 11
Gene Therapy and Dermatology: More Than Just Skin Deep
Somani, A.-K. B., Esmail, N., & Siminovitch, K. A. (1999) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347549900300508 · Cited by 11
Current challenges of gene therapy for prostate cancer.
Harrison, G. S., & Glode, L. M. (1997) · PubMed · Cited by 11
Metadata
- Authors
- Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., & Moen, R.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-10-01
- Volume
- 176
- Issue
- 4
- Pages
- 1125-1135
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2119385
- OpenAlex
- W2132859839
- Cited by
- 532
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2022: 8 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 10 · 2017: 7 · 2015: 8 · 2014: 11 · 2013: 5 · 2012: 9
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Keywords
- Moloney murine leukemia virus, retroviral vectors, replication-competent virus, T-cell lymphoma, helper virus, retroviral gene transfer, CD34+ hematopoietic stem cells, bone marrow transplantation, rhesus monkeys, non-human primates, gene therapy safety, thymic lymphoma
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Differentiation, Base Sequence, Cells, Cultured, DNA, Neoplasm, DNA, Viral, Globins, Helper Viruses, Macaca mulatta, Molecular Sequence Data, Moloney murine leukemia virus, Oligodeoxyribonucleotides, Time Factors, Transfection, Virus Replication, Antigens, CD, Bone Marrow Transplantation, Lymphoma, T-Cell, Genome, Viral, Antigens, CD34
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review